About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2021
2020
2019
2018
2017
2016
05
Nov
2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
Read more
04
Nov
2020
00:00 E.S.T.
American Society of Hematology (ASH) Abstract Shows Initial Anti-Leukemic Activity of UCART22 in BALLI-01 Phase 1 Study in R/R Adult B-ALL
Read more
21
Oct
2020
16:30 E.S.T.
Cellectis to Hold Third Quarter 2020 Earnings Call on Friday, November 6, 2020 at 8:00AM EST
Read more
16
Oct
2020
08:15 E.S.T.
Calyxt Announces $15 Million Registered Direct Offering
Read more
02
Sep
2020
16:30 E.S.T.
Cellectis to Participate in Upcoming Investor Conferences
Read more
05
Aug
2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2020
Read more
29
Jul
2020
16:30 E.S.T.
Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT
Read more
21
Jul
2020
16:30 E.S.T.
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing
Read more
06
Jul
2020
17:20 E.S.T.
To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors
Read more
06
Jul
2020
16:50 E.S.T.
Cellectis Reports Clinical Hold Placed on MELANI-01 Study
Read more
Prev
1
2
3
4
Next